TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium
LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing...
Year: 2023
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
VELDONA® positioned as a potential treatment option for over 24,000 HIV-seropositive AmericansSAN DIEGO, CA / ACCESSWIRE / September 18, 2023...
LAPIX Therapeutics Inc. Announces FDA Clearance of IND Application for its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable...
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
Jonathan Kennedy, Chief Financial Officer, Route 92 Medical Jonathan Kennedy has just joined Route 92 Medical as Chief Financial Officer....
KabaFusion Selects Inovalon ScriptMed® Infusion Cloud Solution
One of the Nation’s Largest Infusion Pharmacy Networks Selects Inovalon’s Leading Cloud Native Solution, ScriptMed® Infusion, to Advance Patient-Centric Care...
UpHealth Comments on Needham Action Ruling
Believes Court Erred by Ignoring Settled New York Law and Decades of Precedent Company is Exploring All Options in Response...
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive...
Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available Evaxion’s proprietary AI-platforms...
Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused...
Aruna Bio Announces Presentation on the Mechanism of its Neural Exosome Platform and Lead Program, AB126, at the BioProcess International Conference & Exhibition
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory and neuroprotective properties through modulation...
77% of Employers Plan to Increase Investment in Virtual Health Care, says Teladoc Health’s 2023 Virtual Care Transformation Index
Findings from annual study also reinforce the value of whole-person care, equitable access and a balanced approach to GLP-1s &...
Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)
- Topline results from this study are expected in early Q1 2024 - Celltrion has a right of first negotiation...
Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer
Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencingSALT LAKE CITY, Sept. 18, 2023 (GLOBE NEWSWIRE) --...
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- TRACON...
Apnimed Appoints John Yee, MD, MPH, as SVP, Medical Affairs
- Seasoned biopharma medical leader joins Apnimed as it initiates its Phase 3 clinical program for AD109, a potential new...
Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library
Planegg/Martinsried, September 18, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the...
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
HOLLISTER, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference
Morgan Stanley Fireside Chat Replay Now AvailableSAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the...
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands
Enables the efficient expansion of surface targets for radioisotope deliveryINDIANAPOLIS and SCHLIEREN-ZURICH, Switzerland, Sept. 18, 2023 (GLOBE NEWSWIRE) -- POINT...
Safety Shot to Develop Detox Product for Alcohol Poising, Plans to File IND with U.S. FDA
Concentrated form of Safety Shot may be effective as a rapid treatment for alcohol poising which causes 2,200 deaths each...